Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)

Lau G.Mahidol University2023-06-202023-06-202022-04-01Hepatology International Vol.16 No.2 (2022) , 486-48719360533https://repository.li.mahidol.ac.th/handle/20.500.14594/87345Unfortunately, the first and last name of the Co-author, Tawesak Tanwandee has been interchanged in the original publication of the article. The correct first name should read as “Tawesak” and the last name should read as “Tanwandee” respectively.MedicineCorrection to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (Hepatology International, (2021), 15, 5, (1031-1048), 10.1007/s12072-021-10239-x)ErratumSCOPUS10.1007/s12072-022-10301-22-s2.0-851235066041936054135076895